As shown in Fig. 5c,d, co-implanting either type of MSCs with breast cancer cells increased primary tumor volumes and promoted the progression of the EMT, as shown by the presence of vimentin- or fibronectin-positive areas in primary tumors. This evidence concerns the gene VIM and breast carcinoma.